Cetuximab, Leucovorin, Oxaliplatin, and Fluorouracil With or Without Bevacizumab in Treating Patients With Resectable Liver Metastases From Colorectal Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Colorectal Cancer
Related studies linked through entity extraction aliases.
A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Colonoscopy by Videocapsuls Versus Standard Colonoscopy. Intra-individual Comparison for the Subject With a Medium or High Risk of Colorectal Cancer.
- Status
- COMPLETED
- Phase
- NA
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Improving Followup of Abnormal Colon Cancer Screening Tests
- Status
- COMPLETED
- Phase
- NA
ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC)
- Status
- UNKNOWN
- Phase
- PHASE3
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
- Status
- COMPLETED
- Phase
- N/A
Capecitabine and Oxaliplatin or Standard Follow-Up Care in Treating Patients Who Have Undergone Surgery for Locally Advanced Rectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Fluorouracil, Semustine, and Vincristine Compared With BCG in Treating Patients With Dukes' B or Dukes' C Colon Cancer That Has Been Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Liver Infusions of Fluorouracil in Treating Patients With Dukes' A, Dukes' B, or Dukes' C Colon Cancer Undergoing Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Study for Patients Who Have Benefited and Tolerated Prior Panitumumab Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Fluorouracil and Leucovorin and/or Levamisole After Surgery In Treating Patients With Dukes' B Or Dukes' C Colon Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Bevacizumab and Combination Chemotherapy as First-Line Therapy in Treating Patients With Metastatic Colorectal Cancer That Cannot Be Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Colon Investigation - Factors Determining Choice of Procedure
- Status
- TERMINATED
- Phase
- N/A
Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
SPIRITT - Second-Line Panitumumab Irinotecan Treatment Trial
- Status
- COMPLETED
- Phase
- PHASE2
Collection of Patient-Reported Symptoms and Performance Status Via the Internet
- Status
- COMPLETED
- Phase
- NA
Capecitabine, Oxaliplatin, and Bevacizumab in Treating Patients With Metastatic or Recurrent Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Panitumumab Regimen Evaluation in Colorectal Cancer to Estimate Primary Response to Treatment
- Status
- COMPLETED
- Phase
- PHASE2